Stock Earnings
Guggenheim downgrades Altimmune Inc (ALT) stock to a Neutral
Altimmune Inc’s recently made public that its Director Drutz David unloaded Company’s shares for reported $0.11 million on Aug 19
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.